TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/24 16:24 | 1/26/24 | DFS | Discover Financial Services | DE | Financ | Loan | Personal Credit Institutions | Greene John | IL | O | EVP,CFO | S | -3,748 | 106.51 | 0 | -35 | -65 | 19 | D | ||||||||||||||
2/17/22 17:11 | 2/15/22 | DFS | Discover Financial Services | DE | Financ | Loan | Personal Credit Institutions | Greene John | IL | O | EVP,CFO | S | -568 | 127.95 | 0 | -4 | -14 | 27 | D | ||||||||||||||
1/27/20 18:28 | 1/27/20 | DFS | Discover Financial Services | DE | Financ | Loan | Personal Credit Institutions | Greene John | IL | O | EVP,CFO | P | 249 | 73.84 | 0 | 3 | 14 | 28 | D | ||||||||||||||
2/15/18 17:24 | 2/14/18 | BIVV | Bioverativ Inc. | DE | Health | Drug | Pharmaceutical Preparations | Greene John | MA | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 7 | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |